EU MDR Compliance
EU MDR Cybersecurity Compliance for Medical Device Manufacturers
We support EU MDR cybersecurity expectations for connected devices covering Annex I GSPR 17.2, MDCG 2019-16, and the upcoming EU Cyber Resilience Act.

Medysec Deliverables
What EU MDR Cybersecurity Deliverables Does We Provide
We build the security evidence needed across risk management, threat modeling, software security, testing, vulnerability management, and postmarket activities.
Threat Model
Security Architecture
Security Requirements Specification (SRS)
SBOM (Software Bill of Materials)
Security Verification & Validation Report
Vulnerability Management & Patching Policy
Cybersecurity Risk Assessment
Cybersecurity Risk Management File
Post-Market Cybersecurity Surveillance Process
Incident Handling & Regulatory Reporting Procedure
Cybersecurity Control Catalogue
Cybersecurity Traceability Matrix
Penetration Test (VAPT Report)
Computer Incident Security Incident Management
Our Compliance Process
Our EU MDR Compliance Process Workflow
We connect applicable MDR requirements to product architecture, cybersecurity risks, testing, and the technical record.
Standards & Framework
Standards and Frameworks We Follow
Our work is informed by the EU MDR requirements and guidance relevant to your device and cybersecurity evidence.
- Regulation (EU) 2017/745
- MDR Annex I
- MDR Annex II
- MDR Annex III
- MDCG 2019-16 Rev. 1
- MDCG 2019-11 Rev. 1
- MDCG 2020-3 Rev. 1
- MDCG 2025-10
- MDR GSPR
Step-by-Step Workflow
How to Begin Securing Your MedTech Cybersecurity with Medysec
We analyze your device architecture, build complete cybersecurity evidence, and hand your team an audit-ready submission package.
- 01
Discovery & Artifact Plan
Our senior Medysec expert reads device architecture, intended use, regulatory pathway, and existing cybersecurity evidence then delivers a written artifact plan and fixed-fee quote inside 5 business days.
- 02
Authoring & Testing
Medysec runs hands-on threat modeling, SBOM authoring, security risk assessment, and penetration testing on the named device, using the agreed artifact plan as the work contract.
- 03
Internal Reviewer Simulation
Two named Medysec experts review the package against FDA 2026 guidance check-by-check before handoff. Findings flagged, retested, and closed.
- 04
Submission Hand-off
You get a one-hour walk-through with your regulatory lead, a Letter of Attestation, and a fixed-fee retest commitment if FDA raises cybersecurity deficiencies.
In Their Words
What Our Clients Say
We work alongside device manufacturers to secure their connected medical devices and clear regulatory review. Here is what those teams have to say about us.


Qualysec Technologies Pvt Ltd's efforts resulted in improved security, risk mitigation, enhanced security controls, and compliance achievement. The team was responsive, flexible, and open to addressing the client's evolving needs. They maintained regular communication via email and virtual meetings.
Billy Sadhu Sharma Kumar
Head-V&V Engineering

EU MDR Case Studies
Security Evidence for European Market Access

An European MedTech Startup Secures Its Diagnostic Desktop App With Medysec Ahead of FDA 510(k) Submission
A security assessment of a diagnostic desktop application used with the TearView platform, focused on protecting patient diagnostic data, strengthening application controls, and supporting the client’s FDA 510(k) documentation.
Read Case Study
Building a practical threat-modeling process for a healthcare platform
A healthcare platform engagement that clarified security ownership, mapped critical attack paths, and improved evidence for release decisions.
Read Case Study
Securing cloud services behind a patient-facing health application
A practical cloud security review that helped a patient-facing product prioritise its most important configuration and access-control improvements.
Read Case StudyEU MDR FAQ
Frequently Asked Questions
Ready to Map Your Cybersecurity to EU MDR?
Tell us what you are working on and we will give you a straight read on scope, timeline, and cost.

